Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Offers Jobs Courses Forums Movies Games
Sign In Sign Up
Night Mode
Targeted Mucosal Immunomodulators and Endothelin Receptor Antagonists Transforming IgA Nephropathy Care
Slowing progressive renal function decline in patients with IgA Nephropathy (IgAN) is undergoing a major clinical shift toward targeted disease-modifying therapies. Detailed analysis within the IGA Nephropathy Treatment Market report outlines how targeted-release oral corticosteroids, dual endothelin and angiotensin receptor antagonists (sparsentan), and complement pathway inhibitors are...
0 Comments ·0 Shares ·2 Views ·0 Reviews
Please log in to like, share and comment!